GNOM – Global X Genomics & Biotechnology ETF
Global X Genomics & Biotechnology ETF (GNOM) is a Health ETF, issued by Global X Funds, $54.5M in assets, 0.50% expense ratio.
Returns as of Oct 23, 2026: 1 week +2.0%, 1 year +26.4%.
Focuses on companies advancing genomic science and biotechnology, as defined by Solactive AG.
Top holdings
- MRNA – Moderna Inc, 6.1%
- PRAX – Praxis Precision Medicines Inc, 5.9%
- ARWR – Arrowhead Pharmaceuticals Inc, 5.7%
- GH – Guardant Health Inc, 5.6%
- ILMN – Illumina Inc, 5.4%
- NTRA – Natera Inc, 4.4%
- TECH – Bio-Techne Corp, 4.0%
- VRTX – Vertex Pharmaceuticals Inc, 3.8%
- BNTX – BioNTech SE, 3.8%
- BMRN – Biomarin Pharmaceutical Inc, 3.8%
- RNA – Avidity Biosciences Inc, 3.8%
- CRSP – Crispr Therapeutics AG, 3.1%
- VCYT – Veracyte Inc, 2.7%
- ALNY – Alnylam Pharmaceuticals Inc, 2.7%
- LEGN – Legend Biotech Corp, 2.5%
- BEAM – Beam Therapeutics Inc, 2.4%
- BMY – Bristol-Myers Squibb Company, 2.4%
- WGS – GeneDx Holdings Corp., 2.3%
- LLY – Eli Lilly and Company, 2.3%
- AZN – AstraZeneca PLC, 2.1%
- TWST – Twist Bioscience Corp, 2.0%
- TXG – 10X Genomics Inc, 1.9%
- GILD – Gilead Sciences Inc, 1.9%
- 1548 – Genscript Biotech Corp, 1.7%
- RARE – Ultragenyx, 1.7%